Jingyang Wu

Queensland University of Technology — Australia

Medicine · Health Sciences

25h-index3.0kcitations99works1.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(24), Retinal Imaging and Analysis(18), Cytomegalovirus and herpesvirus research(15), Cancer-related molecular mechanisms research(8), Herpesvirus Infections and Treatments(8)

Publications99 total

Does subindustry disclosure policy affect auditor information supply? Evidence from China
International Review of Financial Analysis·2025
Machine learning-based correlation analysis of decadal cyclone intensity with sea surface temperature: data and tutorial
arXiv (Cornell University)·2025Open Access
Does Sub-Industry Disclosure Policy Affect Auditor Information Supply? Evidence from China
SSRN Electronic Journal·2025Open Access
LncRNA WT1-AS/mir-494-3P Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway In Non-Small Cell Lung Cancer [Retraction]
OncoTargets and Therapy·2024Open Access
Review of deep learning models for crypto price prediction: implementation and evaluation
arXiv (Cornell University)·2024· 8 citedOpen Access
Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies
Clinical Pharmacology in Drug Development·2024· 3 citedOpen Access
AURORA: A New Dawn
Clinical Infectious Diseases·2024Open Access
AstroGate: A Conceptual Design Study for a post-ISS Commercial Crewed Space Station
2024
Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer
Clinical Medicine Insights Oncology·2024· 3 citedOpen Access
LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p
Journal of Cancer·2024· 2 citedOpen Access
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
Clinical Infectious Diseases·2023· 44 citedOpen Access
Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open‐Label Study
Clinical Pharmacology in Drug Development·2023· 5 citedOpen Access
miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells
The American Journal of the Medical Sciences·2023· 7 citedOpen Access
Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study
The Journal of Clinical Pharmacology·2022· 8 citedOpen Access
C1QTNF6 regulated by miR‐29a-3p promotes proliferation and migration in stage I lung adenocarcinoma
BMC Pulmonary Medicine·2022· 21 citedOpen Access
A targeted <scp>siRNA</scp>‐loaded <scp>PDL1</scp>‐exosome and functional evaluation against lung cancer
Thoracic Cancer·2022· 23 citedOpen Access
Assessment of Discontinuations and Anti-Cytomegalovirus Treatment Switching in Post-Transplant Refractory/ Resistant Cytomegalovirus Infections: Safety and Sensitivity Analyses from a Phase 3 Randomized Trial
Transplantation and Cellular Therapy·2022
Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level
BMC Cancer·2022· 9 citedOpen Access
Additional file 4 of Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level
Figshare·2022Open Access
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Clinical Infectious Diseases·2021· 277 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lei Liu(18), Song Yue(12), Weiping Teng(7), Lei Chen(7), Desheng Huang(6), Yifan Zhong(6), Guisen Zhang(6), Robin K. Avery(4), Catherine Cordonnier(4), Jiahua Zhang(4), Jie Lian(4), Lei Chen(4), Peng Guan(4), Tadeusz Robak(3), Cynthia A. Sirard(3), Rafael F. Duarte(3), Johan Maertens(3), Francisco M. Marty(3), Genovefa A. Papanicolaou(3), Jin Geng(3)